UK Biotech: Just a Research Department in Waiting?
Big pharma is hungry for UK biotechnology companies, with more acquisitions already in the first three months of this year than in any year for the past decade. But what does this mean for the biotech sector's long-term health, both as an independent industry and a jewel in the crown of the UK economy?